Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD.

Rami L, Solé-Padullés C, Fortea J, Bosch B, Lladó A, Antonell A, Olives J, Castellví M, Bartres-Faz D, Sánchez-Valle R, Molinuevo JL.

Int J Geriatr Psychiatry. 2012 Feb;27(2):127-34. doi: 10.1002/gps.2696. Epub 2011 Mar 7.

PMID:
21384432
2.

Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates.

Molinuevo JL, Gómez-Anson B, Monte GC, Bosch B, Sánchez-Valle R, Rami L.

Arch Gerontol Geriatr. 2011 Mar-Apr;52(2):190-6. doi: 10.1016/j.archger.2010.03.016. Epub 2010 Apr 8.

PMID:
20381176
3.

Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study.

Di Paola M, Macaluso E, Carlesimo GA, Tomaiuolo F, Worsley KJ, Fadda L, Caltagirone C.

J Neurol. 2007 Jun;254(6):774-81. Epub 2007 Apr 3.

PMID:
17404777
4.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

5.

Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease.

Haldenwanger A, Eling P, Kastrup A, Hildebrandt H.

J Alzheimers Dis. 2010;22(3):971-80. doi: 10.3233/JAD-2010-101203.

PMID:
20858947
6.

Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients.

Rami L, Fortea J, Bosch B, Solé-Padullés C, Lladó A, Iranzo A, Sánchez-Valle R, Molinuevo JL.

J Alzheimers Dis. 2011;23(2):319-26. doi: 10.3233/JAD-2010-101422.

PMID:
21098971
7.

Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.

Chételat G, Landeau B, Eustache F, Mézenge F, Viader F, de la Sayette V, Desgranges B, Baron JC.

Neuroimage. 2005 Oct 1;27(4):934-46.

PMID:
15979341
8.

Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum.

Solé-Padullés C, Lladó A, Bartrés-Faz D, Fortea J, Sánchez-Valle R, Bosch B, Antonell A, Molinuevo JL, Rami L.

Psychiatry Res. 2011 Jun 30;192(3):140-6. doi: 10.1016/j.pscychresns.2010.12.001. Epub 2011 May 4.

PMID:
21546220
9.

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.

Sluimer JD, Bouwman FH, Vrenken H, Blankenstein MA, Barkhof F, van der Flier WM, Scheltens P.

Neurobiol Aging. 2010 May;31(5):758-64. doi: 10.1016/j.neurobiolaging.2008.06.016. Epub 2008 Aug 8.

PMID:
18692273
10.

Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.

Schmand B, Huizenga HM, van Gool WA.

Psychol Med. 2010 Jan;40(1):135-45. doi: 10.1017/S0033291709991516. Epub 2009 Oct 29.

PMID:
19863841
11.

Neural correlates of verbal episodic memory in patients with MCI and Alzheimer's disease--a VBM study.

Leube DT, Weis S, Freymann K, Erb M, Jessen F, Heun R, Grodd W, Kircher TT.

Int J Geriatr Psychiatry. 2008 Nov;23(11):1114-8. doi: 10.1002/gps.2036.

PMID:
18449954
12.

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.

Schoonenboom NS, van der Flier WM, Blankenstein MA, Bouwman FH, Van Kamp GJ, Barkhof F, Scheltens P.

Neurobiol Aging. 2008 May;29(5):669-75. Epub 2007 Jan 17.

PMID:
17208336
13.

Single- and multiple-domain amnestic mild cognitive impairment: two sides of the same coin?

Brambati SM, Belleville S, Kergoat MJ, Chayer C, Gauthier S, Joubert S.

Dement Geriatr Cogn Disord. 2009;28(6):541-9. doi: 10.1159/000255240. Epub 2009 Dec 14.

PMID:
20016185
14.

The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study.

Sarazin M, Chauviré V, Gerardin E, Colliot O, Kinkingnéhun S, de Souza LC, Hugonot-Diener L, Garnero L, Lehéricy S, Chupin M, Dubois B.

J Alzheimers Dis. 2010;22(1):285-94. doi: 10.3233/JAD-2010-091150.

PMID:
20847406
15.

Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease.

Thomann PA, Kaiser E, Schönknecht P, Pantel J, Essig M, Schröder J.

J Psychiatry Neurosci. 2009 Mar;34(2):136-42.

16.

Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study.

Rémy F, Mirrashed F, Campbell B, Richter W.

Neuroimage. 2005 Mar;25(1):253-66. Epub 2004 Dec 10.

PMID:
15734360
17.

Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer's disease.

Köhler S, Black SE, Sinden M, Szekely C, Kidron D, Parker JL, Foster JK, Moscovitch M, Winocour G, Szalai JP, Bronskill MJ.

Neuropsychologia. 1998 Sep;36(9):901-14. Erratum in: Neuropsychologia 1999 Jan;37(1):123. Wincour G [corrected to Winocour G].

PMID:
9740363
18.

Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study.

Garrido GE, Furuie SS, Buchpiguel CA, Bottino CM, Almeida OP, Cid CG, Camargo CH, Castro CC, Glabus MF, Busatto GF.

J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):508-16.

19.

Relationship of cognitive measures and gray and white matter in Alzheimer's disease.

Baxter LC, Sparks DL, Johnson SC, Lenoski B, Lopez JE, Connor DJ, Sabbagh MN.

J Alzheimers Dis. 2006 Aug;9(3):253-60.

PMID:
16914835
20.

[Neuropsychological correlates of cerebral atrophy in Alzheimer's dementia].

Pantel J, Schönknecht P, Essig M, Schröder J.

Fortschr Neurol Psychiatr. 2004 Apr;72(4):192-203. German.

PMID:
15095176

Supplemental Content

Support Center